Patents by Inventor Cornelis Arjan Van Oeveren

Cornelis Arjan Van Oeveren has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 5-cycloalkenyl 5H-chromeno[3,4-f]quinoline derivatives as selective progesterone receptor modulator compounds
    Patent number: 7071205
    Abstract: The present invention is directed to compounds, pharmaceutical compositions, and methods for modulating processes mediated by Progesterone Receptor. Also provided are methods of making such compounds and pharmaceutical compositions.
    Type: Grant
    Filed: October 10, 2003
    Date of Patent: July 4, 2006
    Assignee: Ligand Pharmaceuticals Incorporated
    Inventors: Lin Zhi, Cornelis Arjan Van Oeveren, Bijan Pedram, Donald S. Karanewsky
  • Tricyclic androgen receptor modulator compounds and methods
    Patent number: 7026484
    Abstract: This invention relates to non-steroidal tricyclic compounds that are modulators of androgen receptors and to methods for making and using such compounds.
    Type: Grant
    Filed: February 22, 2002
    Date of Patent: April 11, 2006
    Assignee: Ligand Pharmaceuticals Incorporated
    Inventors: Lin Zhi, Cornelis Arjan Van Oeveren, Jyun-Hung Chen, Robert I. Higuchi
  • 5-cycloalkenyl 5H-chromeno[3,4-f]quinoline derivatives as selective progesterone receptor modulator compounds
    Publication number: 20040152718
    Abstract: The present invention is directed to compounds, pharmaceutical compositions, and methods for modulating processes mediated by Progesterone Receptor. Also provided are methods of making such compounds and pharmaceutical compositions.
    Type: Application
    Filed: October 10, 2003
    Publication date: August 5, 2004
    Inventors: Lin Zhi, Cornelis Arjan van Oeveren, Bijan Pedram, Donald Karanewsky
  • 5-Substituted 7,9-difluoro-5H-chromeno[3,4-f]quinoline compounds as selective progesterone receptor modulator compounds
    Publication number: 20040152717
    Abstract: The present invention is directed to compounds, pharmaceutical compositions, and methods for modulating processes mediated by progesterone receptor. Also provided are methods of making such compounds and pharmaceutical compositions.
    Type: Application
    Filed: October 10, 2003
    Publication date: August 5, 2004
    Inventors: Lin Zhi, Cornelis Arjan Van Oeveren, Bijan Pedram, Donald S. Karanewsky
  • 5-(1',1'-cycloalkyl/alkenyl)methylidene 1,2-dihydro-5H-chromeno[3,4-f]quinolines as selective progesterone receptor modulator compounds
    Publication number: 20040147530
    Abstract: The present invention is directed to compounds, pharmaceutical compositions, and methods for modulating processes mediated by Progesterone Receptor. Also provided are methods of making such compounds and pharmaceutical compositions.
    Type: Application
    Filed: October 10, 2003
    Publication date: July 29, 2004
    Inventors: Lin Zhi, Cornelis Arjan Van Oeveren
  • Bicyclic androgen and progesterone receptor modulator compounds and methods
    Patent number: 6566372
    Abstract: The present invention is directed to compounds, pharmaceutical compositions, and methods for modulating processes mediated by AR and PR. More particularly, the invention relates to nonsteroidal compounds and compositions that are high affinity, high specificity agonists, partial agonists (i.e., partial activators and/or tissue-specific activators) and antagonists for AR and PR. Also provided are methods of making such compounds and pharmaceutical compositions, as well as critical intermediates used in their synthesis.
    Type: Grant
    Filed: August 24, 2000
    Date of Patent: May 20, 2003
    Assignee: Ligand Pharmaceuticals Incorporated
    Inventors: Lin Zhi, Christopher Tegley, Barbara Pio, Cornelis Arjan Van Oeveren, Mehrnouch Motamedi, Esther Martinborough, Sarah West
  • Tricyclic androgen receptor modulator compounds and methods
    Publication number: 20020183346
    Abstract: This invention relates to non-steroidal tricyclic compounds that are modulators of androgen receptors and to methods for making and using such compounds.
    Type: Application
    Filed: February 22, 2002
    Publication date: December 5, 2002
    Applicant: Ligand Pharmaceuticals Incorporated
    Inventors: Lin Zhi, Cornelis Arjan Van Oeveren, Jyun-Hung Chen, Robert I. Higuchi